|
Name: Equipoise, Parenabol, Vebonol, dehydrotestosterone boldione (androsta-1,4-diene-3,17-dione)
Type: Androgenic steroid
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
|
IV. History
The first known use of equipoise was by A. T. de Beer in 1859. De Beer was a German pharmacist who had synthesized testosterone in 1856, which was sold under the name of Testopel (testosterone pellet).
De Beer was trying to synthesize a compound that could be used as a contraceptive. He was trying to synthesize a compound that could be used as a contraceptive. De Beer was trying to synthesize a compound that could be used as a contraceptive. He was trying to synthesize a compound that could be used as a contraceptive.
De Beer was trying to synthesize a compound that could be used as a contraceptive. He was trying to synthesize a compound that could be used as a contraceptive. He was trying to synthesize a compound that could be used as a contraceptive. He was trying to synthesize a compound that could be used as a contraceptive. He was trying to synthesize a compound that could be used
|
|
V. Legal Information
Equipoise, Parenabol, Vebonol, and Dehydrotestosterone Boldione (Androsta-1,4-diene-3,17-dione) are anabolic steroids with legal restrictions globally due to their potential for abuse in bodybuilding and sports. In the United States, they are regulated under the Anabolic Steroid Control Act of 1990 and classified as controlled substances. The European Union and many other countries also enforce regulations to prevent their misuse. [Source: UNODC].
US Federal Schedule - III
Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are: products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Equipoise and related compounds are anabolic steroids used to increase muscle mass and strength. They can cause muscle growth but also lead to side effects like hormonal imbalances, cardiovascular issues, and liver damage. Short-term use may enhance athletic performance, but long-term use poses significant health risks. Overdose risks include severe hormonal disturbances and cardiovascular problems. Safe use involves medical supervision and adherence to recommended doses. Recent research focuses on their muscle-enhancing effects and potential health risks.  |
|
VII. Psychological Effects
Boldione, an anabolic steroid, affects mood and aggression through androgen receptors. Immediate effects include mood enhancement and increased aggression, with long-term use potentially leading to psychological issues such as depression and cognitive impairments. Research indicates risks of significant mood disturbances and mental health issues with chronic use.
 |
|
VIII. Culture
Equipoise, also known as Boldenone, is an anabolic steroid used to enhance muscle growth. Its cultural significance is associated with bodybuilding and athletic performance. Media coverage often highlights the risks of steroid abuse, including health complications and ethical concerns. Equipoise is used for performance enhancement rather than medicinal purposes and is part of broader discussions about steroid use and regulation.
 |